Study of Nivolumab with Standard of Care Therapy vs Standard of Care Therapy for First-Line Treatment of Metastatic Colorectal Cancer
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
Primary objectives: To compare the efficacy of Nivolumab plus SOC chemotherapy with bevacizumab (Nivo+SOC) with SOC chemotherapy with bevacizumab (SOC) in participants with mCRC Primary endpoints: Progression Free Survival (PFS) by BICR
创建时间：
2018-04-15
